---
document_datetime: 2025-12-02 06:12:26
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/alofisel.html
document_name: alofisel.html
version: success
processing_time: 0.1121812
conversion_datetime: 2025-12-26 19:20:55.269051
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Alofisel

[RSS](/en/individual-human-medicine.xml/66619)

##### Withdrawn

This medicine's authorisation has been withdrawn

darvadstrocel Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Alofisel](#news-on)
- [More information on Alofisel](#more-information-on-alofisel-76185)
- [More information on Alofisel](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 13 December 2024, the European Commission withdrew the marketing authorisation for Alofisel (darvadstrocel) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Takeda Pharma A/S, which notified the European Commission of its decision to permanently stop the marketing of the product in the EU.

Alofisel was granted marketing authorisation in the EU on 23 March 2018 for the treatment of complex perianal fistulas. The European Public Assessment Report (EPAR) for Alofisel is updated to indicate that the marketing authorisation is no longer valid.

Alofisel : EPAR - Summary for the public

Reference Number: EMA/1380/2018

English (EN) (164.68 KB - PDF)

**First published:** 04/04/2018

**Last updated:** 21/01/2025

[View](/en/documents/overview/alofisel-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-614)

български (BG) (229.17 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/bg/documents/overview/alofisel-epar-summary-public_bg.pdf)

español (ES) (162.17 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/es/documents/overview/alofisel-epar-summary-public_es.pdf)

čeština (CS) (208.78 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/cs/documents/overview/alofisel-epar-summary-public_cs.pdf)

dansk (DA) (158.61 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/da/documents/overview/alofisel-epar-summary-public_da.pdf)

Deutsch (DE) (167.33 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/de/documents/overview/alofisel-epar-summary-public_de.pdf)

eesti keel (ET) (153.27 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/et/documents/overview/alofisel-epar-summary-public_et.pdf)

ελληνικά (EL) (234.43 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/el/documents/overview/alofisel-epar-summary-public_el.pdf)

français (FR) (165.99 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/fr/documents/overview/alofisel-epar-summary-public_fr.pdf)

hrvatski (HR) (195.46 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/hr/documents/overview/alofisel-epar-summary-public_hr.pdf)

italiano (IT) (156.75 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/it/documents/overview/alofisel-epar-summary-public_it.pdf)

latviešu valoda (LV) (203.09 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/lv/documents/overview/alofisel-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (197.83 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/lt/documents/overview/alofisel-epar-summary-public_lt.pdf)

magyar (HU) (190.24 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/hu/documents/overview/alofisel-epar-summary-public_hu.pdf)

Malti (MT) (206.96 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/mt/documents/overview/alofisel-epar-summary-public_mt.pdf)

Nederlands (NL) (163.83 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/nl/documents/overview/alofisel-epar-summary-public_nl.pdf)

polski (PL) (210.32 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/pl/documents/overview/alofisel-epar-summary-public_pl.pdf)

português (PT) (161.5 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/pt/documents/overview/alofisel-epar-summary-public_pt.pdf)

română (RO) (201.52 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/ro/documents/overview/alofisel-epar-summary-public_ro.pdf)

slovenčina (SK) (196.4 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/sk/documents/overview/alofisel-epar-summary-public_sk.pdf)

slovenščina (SL) (187.62 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/sl/documents/overview/alofisel-epar-summary-public_sl.pdf)

Suomi (FI) (154.29 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/fi/documents/overview/alofisel-epar-summary-public_fi.pdf)

svenska (SV) (158.01 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/sv/documents/overview/alofisel-epar-summary-public_sv.pdf)

Alofisel : EPAR - Risk-management-plan summary

English (EN) (272.07 KB - PDF)

**First published:** 29/07/2019

**Last updated:** 21/01/2025

[View](/en/documents/rmp-summary/alofisel-epar-risk-management-plan-summary_en.pdf)

## Product information

Alofisel : EPAR - Product information

English (EN) (932.56 KB - PDF)

**First published:** 04/04/2018

**Last updated:** 21/01/2025

[View](/en/documents/product-information/alofisel-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-886)

български (BG) (1.22 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/bg/documents/product-information/alofisel-epar-product-information_bg.pdf)

español (ES) (1.13 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/es/documents/product-information/alofisel-epar-product-information_es.pdf)

čeština (CS) (1.25 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/cs/documents/product-information/alofisel-epar-product-information_cs.pdf)

dansk (DA) (1.06 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/da/documents/product-information/alofisel-epar-product-information_da.pdf)

Deutsch (DE) (1.15 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/de/documents/product-information/alofisel-epar-product-information_de.pdf)

eesti keel (ET) (986.52 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/et/documents/product-information/alofisel-epar-product-information_et.pdf)

ελληνικά (EL) (1.24 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/el/documents/product-information/alofisel-epar-product-information_el.pdf)

français (FR) (1.19 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/fr/documents/product-information/alofisel-epar-product-information_fr.pdf)

hrvatski (HR) (1.12 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/hr/documents/product-information/alofisel-epar-product-information_hr.pdf)

íslenska (IS) (926.44 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/is/documents/product-information/alofisel-epar-product-information_is.pdf)

italiano (IT) (1.01 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/it/documents/product-information/alofisel-epar-product-information_it.pdf)

latviešu valoda (LV) (1.25 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/lv/documents/product-information/alofisel-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.26 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/lt/documents/product-information/alofisel-epar-product-information_lt.pdf)

magyar (HU) (1.24 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/hu/documents/product-information/alofisel-epar-product-information_hu.pdf)

Malti (MT) (1.36 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/mt/documents/product-information/alofisel-epar-product-information_mt.pdf)

Nederlands (NL) (1.19 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/nl/documents/product-information/alofisel-epar-product-information_nl.pdf)

norsk (NO) (922.99 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/no/documents/product-information/alofisel-epar-product-information_no.pdf)

polski (PL) (1.29 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/pl/documents/product-information/alofisel-epar-product-information_pl.pdf)

português (PT) (1.1 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/pt/documents/product-information/alofisel-epar-product-information_pt.pdf)

română (RO) (1.28 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/ro/documents/product-information/alofisel-epar-product-information_ro.pdf)

slovenčina (SK) (1.22 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/sk/documents/product-information/alofisel-epar-product-information_sk.pdf)

slovenščina (SL) (1.2 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/sl/documents/product-information/alofisel-epar-product-information_sl.pdf)

Suomi (FI) (1.02 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/fi/documents/product-information/alofisel-epar-product-information_fi.pdf)

svenska (SV) (1.06 MB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/sv/documents/product-information/alofisel-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** II/0044/G 14/09/2023

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Alofisel : EPAR - All Authorised presentations

English (EN) (87.98 KB - PDF)

**First published:** 04/04/2018

**Last updated:** 21/01/2025

[View](/en/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-106)

български (BG) (103.43 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/bg/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_bg.pdf)

español (ES) (89.2 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/es/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_es.pdf)

čeština (CS) (108.66 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/cs/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (91.14 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/da/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (85.87 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/de/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (87.35 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/et/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (112.39 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/el/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_el.pdf)

français (FR) (89.09 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/fr/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (121.92 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/hr/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (86.15 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/is/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_is.pdf)

italiano (IT) (88.69 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/it/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (108.09 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/lv/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (104.94 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/lt/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (104.65 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/hu/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (111.89 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/mt/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (91.7 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/nl/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (91.26 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/no/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_no.pdf)

polski (PL) (112.44 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/pl/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_pl.pdf)

português (PT) (86.52 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/pt/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_pt.pdf)

română (RO) (107.03 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/ro/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (107.9 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/sk/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (99.11 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/sl/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (89.58 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/fi/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (88.67 KB - PDF)

**First published:**

04/04/2018

**Last updated:**

21/01/2025

[View](/sv/documents/all-authorised-presentations/alofisel-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Alofisel Active substance darvadstrocel International non-proprietary name (INN) or common name darvadstrocel Therapeutic area (MeSH) Rectal Fistula Anatomical therapeutic chemical (ATC) code L04

### Pharmacotherapeutic group

Immunosuppressants

### Therapeutic indication

Alofisel is indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn's disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy. Alofisel should be used after conditioning of fistula.

## Authorisation details

EMA product number EMEA/H/C/004258

Advanced therapy

This medicine is classified as an advanced therapy medicinal product (ATMP): a medicine for human use that is based on genes, tissues or cells. It offers groundbreaking new opportunities for the treatment of disease and injury. For more information, see [Advanced therapy medicinal products: Overview](/node/69659) .

Marketing authorisation holder

Takeda Pharma A/S

Delta Park 45

Opinion adopted 14/12/2017 Marketing authorisation issued 23/03/2018 Withdrawal of marketing authorisation 13/12/2024 Revision 12

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Alofisel : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (894.69 KB - PDF)

**First published:** 30/05/2018

**Last updated:** 21/01/2025

[View](/en/documents/procedural-steps-after/alofisel-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

Alofisel-H-C-004258-II-0051-G : EPAR - Assessment report - Variation

Reference Number: EMA/598555/2024

English (EN) (4.51 MB - PDF)

**First published:** 26/03/2025

[View](/en/documents/variation-report/alofisel-h-c-004258-ii-0051-g-epar-assessment-report-variation_en.pdf)

## Initial marketing authorisation documents

Alofisel : Orphan maintenance assessment report (initial authorisation)

Reference Number: EMA/92608/2018

English (EN) (563.62 KB - PDF)

**First published:** 04/04/2018

**Last updated:** 21/01/2025

[View](/en/documents/orphan-maintenance-report/alofisel-orphan-maintenance-assessment-report-initial-authorisation_en.pdf)

Alofisel : EPAR - Public assessment report

Adopted

Reference Number: EMA/CHMP/64055/2018

English (EN) (4.69 MB - PDF)

**First published:** 04/04/2018

**Last updated:** 21/01/2025

[View](/en/documents/assessment-report/alofisel-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Alofisel

Adopted

Reference Number: EMA/CHMP/815767/2017

English (EN) (121.12 KB - PDF)

**First published:** 15/12/2017

**Last updated:** 21/01/2025

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-alofisel_en.pdf)

#### News on Alofisel

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 December 2024](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-9-12-december-2024) 13/12/2024

[Alofisel withdrawn from the EU market](/en/news/alofisel-withdrawn-eu-market) 13/12/2024

[New medicine to treat perianal fistulas in patients with Crohn's disease](/en/news/new-medicine-treat-perianal-fistulas-patients-crohns-disease) 15/12/2017

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 December 2017](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-11-14-december-2017) 15/12/2017

#### More information on Alofisel

This product was originally [designated an orphan medicine](https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-09-667) on 8 October 2009. Alofisel was withdrawn from the Community register of orphan medicinal products by the European Commission in December 2024 at the time of the withdrawal of the marketing authorisation.

#### More information on Alofisel

- [EMEA-001561-PIP01-13-M02 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-001561-pip01-13-m02)
- [Alofisel - direct healthcare professional communication (DHPC)](/en/medicines/dhpc/alofisel)
- [Alofisel-4001: Postauthorization Safety Study of the Long-Term Safety and Efficacy of Repeat Administration of Darvadstrocel in Patients With Crohn's Disease and Complex Perianal Fistula - post-authorisation study](https://catalogues.ema.europa.eu/study/44182)
- [An Observational European Multi-database Linkage Study to Quantify Malignancy Rates in Crohn's Disease Patients With Complex Perianal Fistula Treated With Darvadstrocel (Alofisel-5005) - post-authorisation study](https://catalogues.ema.europa.eu/study/103350)

**This page was last updated on** 29/04/2025

## Share this page

[Back to top](#main-content)